EarningsQ2 2025 Earnings Report

Atara Biotherapeutics (ATRA) Q2 2025 Earnings Report

0 Followers

CH:ATRA Q2 2025 EPS Results

Actual EPSCHF0.16

Consensus EPS-CHF0.05

Beat/MissBeat by +CHF0.21

One Year Ago EPS-CHF2.58

Actual RevenueCHF14.60M

Expected RevenueCHF6.11M

Beat/MissBeat by +CHF8.49M

YoY Revenue Growth-38.63%

QuarterQ2 2025

Date08/11/2025

TimeAfter Close

Conference CallMonday, August 11, 2025

CH:ATRA Upcoming Earnings

Atara Biotherapeutics's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	-0.11 / -	-0.266	―
Aug 12, 2026	2026 (Q2)	-0.26 / -0.27	0.158	-268.42% (-0.42)
May 12, 2026	2026 (Q1)	-0.27 / -0.24	2.907	-108.29% (-3.15)
Mar 16, 2026	2025 (Q4)	-0.15 / -0.21	-0.989	78.99% (+0.78)
Nov 29, 2025	2025 (Q3)	-0.55 / -0.27	-2.434	89.08% (+2.17)
Aug 11, 2025	2025 (Q2)	-0.05 / 0.16	-2.575	106.13% (+2.73)
May 15, 2025	2025 (Q1)	-1.64 / 2.91	-4.777	160.87% (+7.68)
Mar 07, 2025	2024 (Q4)	-2.38 / -0.99	-11.63	91.50% (+10.64)
Nov 12, 2024	2024 (Q3)	-1.57 / -2.43	-13.707	82.24% (+11.27)
Aug 12, 2024	2024 (Q2)	-1.86 / -2.58	-14.122	81.76% (+11.55)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed